Although Artemisia iwayomogi (AI) has been shown to improve the lipid metabolism, its mode of action is poorly understood. In this study, a 95% ethanol extract of AI (95EEAI) was identified as a potent ligand of peroxisome proliferator-activated receptorδ (PPARδ) using ligand binding analysis and cell-based reporter assay. In cultured primary human skeletal muscle cells, treatment of 95EEAI increased expression of two important PPARδ-regulated genes, carnitine palmitoyl-transferase-1 (CPT1) and pyruvate dehydrogenase kinase isozyme 4 (PDK4), and several genes acting in lipid efflux and energy expenditure. Furthermore, 95EEAI stimulated fatty acid oxidation in a PPARδ-dependent manner. High-fat diet-induced obese mice model further indicated that administration of 95EEAI attenuated diet-induced obesity through the activation of fatty acid oxidation in skeletal muscle. These results suggest that a 95% ethanol extract of AI may have a role as a new functional food material for the prevention and/or treatment of hyperlipidermia and obesity.
References
[1]
de Lange P, Moreno M, Silvestri E, Lombardi A (2007) Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms. FASEB J 21: 3431–3441.
[2]
Palou A, Remesar X, Arola L, Alemany M (1983) Body and organ size and composition during late foetal and postnatal development of rat. Comp Biochem Physiol 75: 597–601.
[3]
Ehrenborg E, Krook A (2009) Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta. Pharmacol Rev 61: 373–393.
[4]
Dressel U, Allen TL, Pippal JB, Rohde PB, Lau P, et al. (2003) The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17: 2477–2493.
[5]
Schuler M, Ali F, Chambon C, Duteil D, Bomert JM, et al. (2006) PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab 4: 407–414.
[6]
Wang YX, Lee CH, Tiep S, Yu RT, Ham J, et al. (2003) Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 18: 159–170.
[7]
Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, et al. (2005) Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 3: 1532–1539.
[8]
Wagner KD, Wagner N (2010) Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions. Pharmacol Ther 125: 423–435.
[9]
Coll T, Rodr？guez-Calvo R, Barroso E, Serrano L, Eyre E, et al. (2009) Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome. Curr Mol Pharmacol 2: 46–55.
[10]
William TC, Jianping Y, Aamir Z, David MR, Ilya R, et al. (2008) Botanicals and the metabolic syndrome. Am J Clin Nutr 2008, 87: 481s–487s.
Nam SM, Ham SS, Oh DH, Kang IJ, Lee SY, et al. (1998) Effects of Artemisia iwayomogi KITAMURA ethanol extracts on lowering serum and liver lipids in rats. J Kor Soc Food Sci Nutr 27: 201–365.
[13]
Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high-throughput screening assays. J Biomol Screen 4: 67–73.
[14]
Kr？mer DK, Al-Khalili L, Perrini S, Skogsberg J, Wretenberg P, et al. (2005) Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta. Diabetes 54: 1157–1163.
[15]
Hamza N, Berke B, Cheze C, Agli A, Robinson P, et al. (2010) Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J Ethnopharmacol 128: 513–518.
[16]
Jung UJ, Baek NI, Chung HG, Jeong TS, Lee KT, et al. (2009) Antilipogenic and hypolipidemic effects of ethanol extracts from two variants of Artemisia princeps Pampanini in obese diabetic mice. J Med Food 12: 1238–1244.
[17]
Lee JM, Chae KS, Ha JR, Park BY, Lee HS (2008) Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaries in high-fat diet-induced obese mice. J Ethnopharmacol 115: 263–270.
[18]
Yamamoto N, Kanemoto Y, Ueda M, Kawasaki K, Fukuda I, et al. (2011) Anti-obesity and anti-diabetic effects of ethanol extract of Artemisia princeps in C57BL/6 mice fed a high-fat diet. Food Funct 2: 45–52.
[19]
Wang ZQ, Ribnicky D, Zhang XH, Zuberi A, Raskin I, et al. (2011) An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice. J Nutr Biochem 22: 71–78.
[20]
Wang ZQ, Ribnicky D, Zhang XH, Raskin I, Yu Y, et al. (2008) Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture. Metabolism 57: S58–S64.
[21]
Oliver WR, Shenk JL, Snaith MR, Russell CS, Plunket KD, et al. (2001) A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 98: 5306–5311.
[22]
Sprecher DL, Massien C, Pearce G, Billin AN, Perlstein I, et al. (2007) Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist. Arterioscler Thromb Vasc Biol 27: 359–365.
[23]
Kramer DK, Khalili LA, Guigas B, Leng Y, Garcia-Roves PM, et al. (2007) Role of AMP kinase and PPARδ in the regulation of lipid and glucose metabolism in human skeletal muscle. J Biol Chem 282: 19313–19320.
[24]
Tanaka T, Yamanoto J, Iwasaki S, Asaba H, Hamura H, et al. (2003) Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100: 15924–15929.
[25]
Brunmair B, Staniek K, Dorig J, Szocs Z, Stadlbauer K, et al. (2006) Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids. Diabetologia 49: 2713–2722.
[26]
Lee CH, Olson P, Hevener A, Mehl I, Chong LW, et al. (2006) PPAR delta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci U S A 103: 3444–3449.
[27]
Tan RX, Zheng WF, Tang HQ (1998) Biologically active substances from the genus Artemisia. Planta Med 64: 295–302.
[28]
Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, et al. (1998) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3: 397–403.
[29]
Forman BM, Chen J, Evans RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci U S A 94: 4312–4317.
[30]
Lee J, Chung WY (2011) The role played by the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) activator, GW501516, in control of fatty acid metabolism: a new potential therapeutic target for treating metabolic syndrome. Endocrinology 152: 1742–1744.
